Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice.

Abstract:

:The present study aimed to investigate the clinical outcomes of percutaneous transhepatic biliary drainage in patients with obstructive jaundice and identify potential predictors of patient survival. Clinical data from 102 patients (66 males and 36 females; median age, 63.50 years; range, 29-84 years) with a mean (± standard deviation) pre-drainage serum bilirubin level of 285.4 (±136.7 μmol/l), were retrospectively studied. Technical and clinical success, complications and survival time were recorded and their relationship with clinical factors, including age, obstruction level, liver metastases, serum bilirubin level and subsequent treatments following drainage, were analyzed by Fisher's exact test. Patient survival rate and other predictors were analyzed by Kaplan-Meier survival curves and Cox's proportional hazard model. The technical and clinical success rates were 100 and 76.5%, respectively. The presence of liver metastases was associated with reduced successful drainage. The overall complication rate was 7.8% and the overall median survival time was 185 days [95% confidence interval (CI), 159-211 days]. A log-rank test showed that age (χ2, 4.003; P=0.04), bilirubin levels following procedure (χ2, 5.139; P=0.02) and subsequent therapy (χ2, 15.459; P=0.00) affected survival time. However, Cox's regression analysis revealed no administration of additional treatments to be a risk factor of survival (odds ratio, 2.323; 95% CI, 1.465-3.685; P=0.000). Percutaneous transhepatic biliary drainage for malignant biliary obstruction was found to be a safe and effective method to relieve jaundice caused by progressive neoplasms. Subsequent radical therapy following drainage, including surgery, chemotherapy and other local treatment types, are likely to increase patient survival.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Zhang GY,Li WT,Peng WJ,Li GD,He XH,Xu LC

doi

10.3892/ol.2014.1860

subject

Has Abstract

pub_date

2014-04-01 00:00:00

pages

1185-1190

issue

4

eissn

1792-1074

issn

1792-1082

pii

ol-07-04-1185

journal_volume

7

pub_type

杂志文章
  • Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression.

    abstract::In the present study, we analyzed the supra-additive effect of oxaliplatin in combination with gemcitabine on terminal colorectal cancer and its influence on high-mobility group box 1 (HMGB1) expression. A total of 86 patients with terminal colorectal cancer were enrolled in this study. Patients received oxaliplatin i...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5053

    authors: Wen S,Du X,Gou Y,Jiang L

    更新日期:2016-11-01 00:00:00

  • Long non-coding RNA LINC00887 promotes progression of lung carcinoma by targeting the microRNA-206/NRP1 axis.

    abstract::Long non-coding RNAs (lncRNAs) have been reported to participate in multiple biological processes, including tumorigenesis. In the current study, the function of a novel lncRNA LINC00887 was investigated in lung carcinoma. For this purpose, LINC00887 expression was assessed by reverse-transcription quantitative PCR. C...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.12348

    authors: Xu LB,Bo BX,Xiong J,Ren YJ,Han D,Wei SH,Ren XP

    更新日期:2021-02-01 00:00:00

  • γ-H2AX as a potential indicator of radiosensitivity in colorectal cancer cells.

    abstract::Preoperative radiotherapy improves local disease control and disease-free survival in patients with advanced rectal cancer; however, a reliable predictive biomarker for the effectiveness of irradiation has yet to be elucidated. Phosphorylation of H2A histone family member X (H2AX) to γ-H2AX is induced by DNA double-st...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11788

    authors: Kawashima S,Kawaguchi N,Taniguchi K,Tashiro K,Komura K,Tanaka T,Inomata Y,Imai Y,Tanaka R,Yamamoto M,Inoue Y,Lee SW,Kawai M,Tanaka K,Okuda J,Uchiyama K

    更新日期:2020-09-01 00:00:00

  • The haplotype of three polymorphisms in the SATB1 promoter region impacts survival in breast cancer patients.

    abstract::Special AT-rich sequence binding protein 1 (SATB1) has regulatory effects on gene expression and appears to play an important role in tumor progression. The present study screened the promoter region of the SATB1 gene for polymorphisms, evaluated the corresponding haplotypes regarding alterations in promoter activity ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.1983

    authors: Heubner M,Kimmig R,Aktas B,Siffert W,Frey UH

    更新日期:2014-06-01 00:00:00

  • CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis.

    abstract::CD133+ tumor cells have a greater potential ability for tumorigenesis, proliferation, invasion and metastasis compared with CD133- tumor cells. Ki-67 is associated with cell proliferation in various tumors and has a markedly positive correlation with the prognosis of patients. However, there are a limited number of st...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1564

    authors: Lu C,Liu L,Wu X,Xu W

    更新日期:2013-11-01 00:00:00

  • Anti-Condyloma acuminata mechanism of microRNAs-375 modulates HPV in cervical cancer cells via the UBE3A and IGF-1R pathway.

    abstract::The present study aimed to identify the probable anti-Condyloma acuminata (CA) mechanism of microRNA-375 (miRNA-375) in human papillomavirus (HPV). Firstly, the overexpression of miRNA-375 significantly suppressed cell proliferation, increased lactate dehydrogenase activity and induced apoptosis in HPV-18(+) cervical ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8983

    authors: Wu S,Chen H

    更新日期:2018-09-01 00:00:00

  • Management of pathological femoral fracture secondary to breast cancer in pregnancy: A case report.

    abstract::Bone metastasis resulting from breast cancer in pregnancy is rare. In the literature there are few reports regarding osteolytic lesions in pregnancy and no data on the treatment of such femoral fractures. The present study reports a case of a 29-week primigravida presenting with severe lumbosciatica in the left side, ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3900

    authors: Ciavattini A,Mancioli F,Paci E,Politano R

    更新日期:2016-01-01 00:00:00

  • Treatment of esophageal-gastric double primary cancer by pedunculated remnant gastric interposition, esophageal-gastric anastomosis and gastrojejunal Billroth II anastomosis: A case report.

    abstract::With the continuous advancement of clinical diagnostic techniques, including imaging technology, the incidence of confirmed multiple primary cancers or double primary carcinoma increases yearly. However, studies reporting synchronization surgery performed for primary dual esophageal gastric cancer are rare. The presen...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3301

    authors: Zhang XT,Wang W,Zhu Q,Cao M,Jiang ZM,Zang QI

    更新日期:2015-08-01 00:00:00

  • Prognosis and treatment differences between initial and second primary chondrosarcoma.

    abstract::Prognosis and treatment differences between initial and second primary chondrosarcoma (pCS) remain unknown. In the present study, patients with chondrosarcoma diagnosed between January 2004 and December 2015 were identified using the Surveillance Epidemiology and End Results database. Kaplan-Meier curves and log-rank ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10329

    authors: Mao W,Kong M,Yu H,Wang D,Huang X,Yao X,Fan J,Geng J

    更新日期:2019-07-01 00:00:00

  • Cluster of differentiation 19 chimeric antigen receptor T-cell therapy in pediatric acute lymphoblastic leukemia.

    abstract::Chimeric antigen receptor (CAR) T cells have an unprecedented positive curative effect for hematological malignances. Most notably, cluster of differentiation 19 (CD19) CAR T-cell therapy for pediatric acute lymphoblastic leukemia is associated with a high complete remission rate and has aroused considerable attention...

    journal_title:Oncology letters

    pub_type: 杂志文章,评审

    doi:10.3892/ol.2020.11897

    authors: Fu Z,Zhou J,Chen R,Jin Y,Ni T,Qian L,Xiao C

    更新日期:2020-10-01 00:00:00

  • Multicentre phase II study of leucovorin plus pharmacokinetic modulating chemotherapy for metastatic colorectal cancer.

    abstract::The optimal administration of 5-fluorouracil (5-FU)/leucovorin (LV) for colorectal cancer (CRC) has yet to be fully defined although evidence of the combination has already been established. In a multicentre phase II study, pharmacokinetic modulating chemotherapy (PMC), which is based on the concept that continuous in...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol_00000014

    authors: Inoue Y,Tanaka K,Hiro J,Toiyama Y,Miki C,Kusunoki M

    更新日期:2010-01-01 00:00:00

  • 18F-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study.

    abstract::The aim of the present study was to evaluate the curative effect of fludeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT)-guided intensity-modulated radiotherapy (IMRT) for 42 patients with International Federation of Gynecology and Obstetrics (FIGO) stage III/IV ovarian cancer. Between Jan...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9601

    authors: Dang YZ,Li X,Ma YX,Li XL,Yang T,Lu WL,Huang SG

    更新日期:2019-01-01 00:00:00

  • Corosolic acid inhibits the proliferation of osteosarcoma cells by inducing apoptosis.

    abstract::Corosolic acid (CRA), a pentacyclic triterpene isolated from medicinal herbs, has been reported to exhibit anticancer properties in several cancers. However, the anticancer activity of CRA in osteosarcoma cells is still unclear. In the present study, the inhibitory effect of CRA in osteosarcoma MG-63 cells was investi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5185

    authors: Jia Y,Yuan H,Shan S,Xu G,Yu J,Zhao C,Mou X

    更新日期:2016-11-01 00:00:00

  • miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.

    abstract::The molecular mechanisms underlying the dysregulation of microRNAs (miRs) have been previously documented in breast cancer. miR-198 has been reported to be deregulated in several human cancers. However, the detailed effects of miR-198 on breast cancer progression remain unclear. Using quantitative polymerase chain rea...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5673

    authors: Hu Y,Tang Z,Jiang B,Chen J,Fu Z

    更新日期:2017-03-01 00:00:00

  • Radiation-induced low-grade fibromyxoid sarcoma of the chest wall nine years subsequent to radiotherapy for breast carcinoma: A case report.

    abstract::The present study reports a case of low-grade fibromyxoid sarcoma that occurred in a 62-year-old woman 9 years subsequent to whole breast irradiation for a carcinoma of the left breast, and 18 years following chemotherapy and radiotherapy (RT) for non-Hodgkin's lymphoma (NHL; diagnosed at the age of 43). The patient w...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4221

    authors: Shibata S,Shiraishi K,Yamashita H,Kobayashi R,Nakagawa K

    更新日期:2016-04-01 00:00:00

  • Propofol promotes apoptosis and suppresses the HOTAIR-mediated mTOR/p70S6K signaling pathway in melanoma cells.

    abstract::Propofol is an intravenous anesthetic, which is widely used in clinical anesthesia induction and maintenance and is critical in the sedation of patients. However, the functions and mechanisms of propofol on apoptosis of melanoma cells remain unclear. The present study investigated whether propofol promotes cell apopto...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7297

    authors: Shang Z,Feng H,Cui L,Wang W,Fu H

    更新日期:2018-01-01 00:00:00

  • Screening of potential therapy targets for prostate cancer using integrated analysis of two gene expression profiles.

    abstract::The aim of the present study was to analyze potential therapy targets for prostate cancer using integrated analysis of two gene expression profiles. First, gene expression profiles GSE38241 and GSE3933 were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between prostate can...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6879

    authors: Zhao R,Wang Y,Zhang M,Gu X,Wang W,Tan J,Wei X,Jin N

    更新日期:2017-11-01 00:00:00

  • Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma.

    abstract::Radiotherapy is the primary treatment for nasopharyngeal carcinoma (NPC), but radioresistance often remains an obstacle to successful treatment. In our previous study, it was demonstrated that Annexin A1 (ANXA1) was involved in the p53-mediated radioresponse in NPC cells, which suggested that it may be associated with...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5324

    authors: Huang L,Liao L,Wan Y,Cheng A,Li M,Chen S,Li M,Tan X,Zeng G

    更新日期:2016-12-01 00:00:00

  • Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

    abstract::Forkhead box M1 (FOXM1) and hedgehog (Hh) signaling pathway are implicated in the formation and development of human tumors, including cervical cancer. Previous studies have indicated that FOXM1 may be a downstream target gene of the Hh signaling pathway, but their association in cervical cancer is largely unknown. In...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4932

    authors: Chen H,Wang J,Yang H,Chen D,Li P

    更新日期:2016-10-01 00:00:00

  • Prostate stem cell antigen is expressed in normal and malignant human brain tissues.

    abstract::Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein and exhibits an organ-dependent expression pattern in cancer. PSCA is upregulated in prostate cancer and downregulated in gastric cancer. PSCA is expressed in a variety of human organs. Although certain studies prev...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7632

    authors: Ono H,Sakamoto H,Yoshida T,Saeki N

    更新日期:2018-03-01 00:00:00

  • Sigmoid adenocarcinoma with metastases to the kidney: Report of a rare case and review of the literature.

    abstract::Distant metastases from colorectal cancer (CRC) most frequently spread to the liver and lungs. CRC metastasis to the kidney is extremely rare and may be generally associated with an unfavorable prognosis. Thus, patients with metastatic CRC and kidney metastasis are a diagnostic and therapeutic challenge. The present s...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3290

    authors: Dulskas A,Bagurskas P,Sinkevicius Z,Samalavicius NE

    更新日期:2015-08-01 00:00:00

  • Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo.

    abstract::Although cisplatin (DDP) has been reported to be a promising antitumor therapy for non-small cell lung cancer (NSCLC), the effectiveness of the treatment remains limited due to an inherent tumor resistance to DDP. Genistein (GEN) is an abundant, naturally occurring isoflavonoid found in soy products that has been demo...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2597

    authors: Liu D,Yan L,Wang L,Tai W,Wang W,Yang C

    更新日期:2014-12-01 00:00:00

  • Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K/AKT signaling pathway.

    abstract::Effects of Rapamycin on the proliferation and apoptosis of retinoblastoma cells through the phosphatidylinositol 3-hydroxy kinase (PI3K)/protein kinase B (AKT) signaling pathway were studied. The retinoblastoma Y79 cells were selected and divided into negative control group (NC group), 0.2 µM Rapamycin group and 0.4 µ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11363

    authors: Yao J,Xu M,Liu Z

    更新日期:2020-04-01 00:00:00

  • Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway.

    abstract::Glioblastomas are the most common primary and malignant brain tumors. The standard therapy includes surgery and radiotherapy plus chemotherapy, with additional bevacizumab to block the angiogenesis in tumors. However, the ever-growing tolerance of glioblastomas to chemotherapeutic drugs impairs the clinical outputs of...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7446

    authors: Huang H,Song J,Liu Z,Pan L,Xu G

    更新日期:2018-02-01 00:00:00

  • High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia.

    abstract::The LIM domain only protein 2 (LMO2) is a key regulator of hematopoietic stem cell development. Expression of LMO2 has been evaluated in B-cell lymphoma, T-cell acute lymphoblastic leukemia and acute myeloid leukemia; however, information concerning its role in breakpoint cluster region/Abelson murine leukemia viral o...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4127

    authors: Aly RM,Taalab MM,Abdsalam EM,Elyamany OH,Hasan OE

    更新日期:2016-03-01 00:00:00

  • Inhibition of cell migration by ouabain in the A549 human lung cancer cell line.

    abstract::The Na+/K+-ATPase α subunit is highly expressed in malignant cells. Ouabain, a cardioactive glycoside, binds to the Na+/K+-ATPase α subunit and inhibits the activity of Na+/K+-ATPase. In the present study, the effect of ouabain on the migration of A549 cells was analyzed using the wound healing and transwell chamber m...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1406

    authors: Liu N,Li Y,Su S,Wang N,Wang H,Li J

    更新日期:2013-08-01 00:00:00

  • Primary pulmonary leiomyosarcoma: A case report.

    abstract::Primary pulmonary leiomyosarcoma (PPL) is an extremely rare malignant tumor. It has been revealed that PPL may originate from the smooth muscle of the pulmonary parenchyma, pulmonary arteries and bronchi. Patients with PPL may be asymptomatic or present with symptoms similar to those observed in other primary lung tum...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4131

    authors: Xie X,Chen Y,Ding C,Yu X,Zou L,Xu B,Wang L,Huang X

    更新日期:2016-03-01 00:00:00

  • Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells.

    abstract::Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated death. Due to rapid progression and metastasis, the long-term survival remains poor for most patients. Thus, it is important to discover and develop novel preventive strategies and therapeutic approaches for HCC. Recent data show that chond...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5466

    authors: Huang Z,Zhang N,Li W,Cao J,Zhang L,Chen Y

    更新日期:2017-02-01 00:00:00

  • Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer.

    abstract::An elevated neutrophil to lymphocyte ratio (NLR) has been reported to be associated with the pathological response to neoadjuvant therapies in numerous types of cancer. The aim of the current study was to clarify the association between pre-treatment NLR and the pathological response to preoperative chemoradiotherapy ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.4057

    authors: Hasegawa S,Eguchi H,Tomokuni A,Tomimaru Y,Asaoka T,Wada H,Hama N,Kawamoto K,Kobayashi S,Marubashi S,Konnno M,Ishii H,Mori M,Doki Y,Nagano H

    更新日期:2016-02-01 00:00:00

  • ADAM9: A novel player in vestibular schwannoma pathogenesis.

    abstract::A disintegrin and metalloproteinase 9 (ADAM9) is a member of the transmembrane ADAM family. It is expressed in different types of solid cancer and promotes tumor invasiveness. To the best of our knowledge, the present study was the first to examine ADAM9 expression in vestibular schwannomas (VS) from patients with and...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11299

    authors: Breun M,Schwerdtfeger A,Martellotta DD,Kessler AF,Monoranu CM,Matthies C,Löhr M,Hagemann C

    更新日期:2020-03-01 00:00:00